Pinned Tweet
🧬🧬🧬 !!!!!
Open comment period closing soon!
🔹Draft Recommendations: Molecular MRD Monitoring in AML 🔹
Read the recommendations and submit your comments here: amp.org/clinical-practice/op…
Deadline: Nov. 24, 2026, at 11:59 p.m. Eastern
130
Madam's an inspiration.
Hyderabad Doctor Brings Down A Rare Disease Drug's Cost From ₹9 Crore To Just ₹2.5 Lakh
Imagine being unable to afford a medicine that could help your child.
For families battling Allan-Herndon-Dudley syndrome (AHDS), a year's supply of tiratricol once cost nearly ₹9 crore.
Now, thanks to Hyderabad paediatrician Dr. Sivaranjani Santosh and Access to Medicines India, seven children will receive a year's supply of the medicine free of cost on November 30.
One doctor's determination is turning an unaffordable treatment into a ray of hope for seven families. ❤️ (TH)
2
155
My biggest regret, ig, is not having done a PhD...& no, not for the degree or the title. It was the life I had imagined for myself. After my MD, a PhD. Taking up a problem & following it to its very end, driving my own project, pursuing a question wherever it led, w/o ...
2
3
113
...remains, folded & tucked away in some obscure corner of my heart. Every now & then, i stumble upon it, unfold it for a little while, & find that beautiful campus, the lab, the late nights & that younger version of me still waiting there. some dreams don't disappear. They ..
1
2
19
So cool
so apparently this robot can now destroy a tumor inside your body using nothing but sound
no cuts, no needles and no radiation, and most patients even go home the same day!
it's called histotripsy, and the company behind the machine (HistoSonics) is backed by Jeff Bezos and valued at $3.75 billion
more than 2,000 people at 50+ US hospitals have already been treated with it
> you lie under a robot arm holding an ultrasound head over your belly
> the doctor marks the tumor on a live ultrasound image
> the robot fires short, intense pulses of sound focused on that one spot
> each pulse makes a cloud of tiny bubbles appear inside the tumor and burst in millionths of a second
> the bursting rips the tumor cells apart until they turn to liquid
> then your immune system clears the mess away over the next few weeks
in the main trial, 90% of the treated liver tumors were still under control a year later
and they're already testing it on kidney tumors and prostates
we're popping cancer with sound now lol
1
2
70
GeneBean retweeted
siRNAs are like the next mAbs in terms of range of what they will do but probably much more dynamic even so
Interesting...
A first of its kind vaccine for acute myeloid leukemia, a deadly blood cancer, succeeded in a Phase 3 clinical trial, drugmaker Sellas Life Sciences and Memorial Sloan Kettering Cancer Center announced. wapo.st/4t6oIRy
1
56
GeneBean retweeted
The biggest advantage of a top lab may not be money.
It may be that it saves you years.
In a weak lab, a PhD student can spend six months chasing a question that everyone in the field already knows is a dead end.
You can build the wrong experiment, optimize the wrong metric, write a paper nobody important cares about, and only discover that after the rejection arrives.
In a great lab, that mistake often dies in a 20-minute meeting.
A senior postdoc has seen the failure before. A collaborator knows the dataset is bad.
Your PI knows which result is merely “interesting” and which one could become a serious paper.
Someone in the room has reviewed for the conference, knows the standard, and can tell you immediately where the story breaks.
That kind of knowledge rarely appears in textbooks.
It gets transmitted over group meetings, draft comments, conference dinners, Slack messages and watching experienced people make decisions in real time.
This is why “research taste” is so unevenly distributed.
Some PhD students have to invent it from scratch.
Others absorb it every week from people who already know what an important problem looks like.
And once you understand that, the advantage of Stanford, MIT, Broad or a top industrial lab starts to look very different.
They are not only giving you better resources.
They are compressing the learning curve.
A mediocre environment can make a talented student waste three years proving things that never mattered.
A great environment can make the same student look “gifted” simply because fewer years were wasted on the wrong problems.
The richest labs do not just buy better experiments.
They buy fewer wasted years.
Put the same PhD student in a small lab and in a powerhouse lab at Stanford, MIT or the Broad Institute, and you are basically running two different careers.
In a top lab, money is rarely the first constraint.
You have better equipment, better datasets, stronger collaborators, experienced postdocs, grant support, and people around you who already know exactly what a Nature, Science, Cell, NeurIPS or CVPR paper is supposed to look like.
Look at the Broad Institute. It has entire genomics, proteomics, imaging and genetic-perturbation platforms built to support projects that a normal university lab could never run alone.
Feng Zhang isn’t just “a very smart professor” — he sits at the intersection of MIT, Broad, McGovern and HHMI. That ecosystem matters.
Same in AI. Fei-Fei Li didn’t build ImageNet in isolation in somebody’s basement.
She was operating inside the Stanford AI ecosystem, surrounded by elite students, collaborators and an institution built to turn ambitious ideas into major projects.
MIT CSAIL is another absurd example: around 1,800 researchers and a research budget of roughly $65 million a year.
A PhD student entering that environment is not starting from the same line as someone in a five-person lab fighting for GPU hours and begging for travel money.
Of course talent still matters. Hard work still matters.
But academia loves pretending everyone is competing on the same track.
They’re not.
Some students spend three years figuring out how the game works.
Others enter a lab where the game manual, the coaches, the equipment and half the winning team are already sitting in the room.
If you seriously want an academic career, choosing the lab may be one of the highest-leverage decisions you ever make.
Genomic Tessellations....imagine a genomic mosaic, not laid out flat like a tiled floor, but folded into a 3D arrangement.... stretches of DNA fitting into a molecular puzzle, forming patterns within patterns...its like nature's own game of Tetris...
GeneBean retweeted
My father, till he lived, never shied away from publically displaying his affection towards my mother. He held her close in all our family photos.. sought her in functions, and proudly displayed his love. He was, perhaps, the happiest around her.
#throwback #photo #family

















